No abstract available
MeSH terms
-
Aged
-
Aminoisobutyric Acids
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / economics
-
Antiviral Agents / therapeutic use*
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / therapeutic use
-
Carbamates / administration & dosage
-
Carbamates / therapeutic use*
-
Cyclopropanes
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Female
-
Genotype
-
Hepacivirus / drug effects
-
Hepacivirus / genetics
-
Hepatitis C / drug therapy*
-
Heterocyclic Compounds, 4 or More Rings / administration & dosage
-
Heterocyclic Compounds, 4 or More Rings / therapeutic use*
-
Humans
-
Lactams, Macrocyclic
-
Leucine / analogs & derivatives
-
Macrocyclic Compounds / administration & dosage
-
Macrocyclic Compounds / therapeutic use
-
Proline / analogs & derivatives
-
Protease Inhibitors / administration & dosage
-
Protease Inhibitors / therapeutic use*
-
Public Health / economics
-
Pyrrolidines
-
Quinoxalines / administration & dosage
-
Quinoxalines / therapeutic use
-
Sofosbuvir / administration & dosage
-
Sofosbuvir / therapeutic use*
-
Sulfonamides / administration & dosage
-
Sulfonamides / therapeutic use
-
Viral Load
-
Viremia / drug therapy*
Substances
-
Aminoisobutyric Acids
-
Antiviral Agents
-
Benzimidazoles
-
Carbamates
-
Cyclopropanes
-
Heterocyclic Compounds, 4 or More Rings
-
Lactams, Macrocyclic
-
Macrocyclic Compounds
-
Protease Inhibitors
-
Pyrrolidines
-
Quinoxalines
-
Sulfonamides
-
voxilaprevir
-
pibrentasvir
-
Proline
-
Leucine
-
glecaprevir
-
velpatasvir
-
Sofosbuvir